Published in J Clin Microbiol on September 01, 2000
Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev (2006) 6.03
Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J Clin Microbiol (2001) 4.89
Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev (2011) 3.63
Rapid-cycle PCR and fluorimetry for detection of mycobacteria. J Clin Microbiol (2002) 2.02
Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis (2003) 1.93
Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J Clin Microbiol (2004) 1.82
Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates from India and Mexico by a molecular beacon assay. J Clin Microbiol (2004) 1.73
Evaluation of antibiotic susceptibilities of three rickettsial species including Rickettsia felis by a quantitative PCR DNA assay. Antimicrob Agents Chemother (2002) 1.53
New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis. J Clin Microbiol (2002) 1.50
Rapid and specific detection of Mycobacterium tuberculosis by using the Smart Cycler instrument and a specific fluorogenic probe. J Clin Microbiol (2003) 1.46
Detection of rpoB mutations in Mycobacterium tuberculosis by biprobe analysis. J Clin Microbiol (2001) 1.41
Dual-probe assay for rapid detection of drug-resistant Mycobacterium tuberculosis by real-time PCR. J Clin Microbiol (2004) 1.41
Rapid and specific detection of Mycobacterium tuberculosis from acid-fast bacillus smear-positive respiratory specimens and BacT/ALERT MP culture bottles by using fluorogenic probes and real-time PCR. J Clin Microbiol (2002) 1.40
Detection of a point mutation associated with high-level isoniazid resistance in Mycobacterium tuberculosis by using real-time PCR technology with 3'-minor groove binder-DNA probes. J Clin Microbiol (2003) 1.37
Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR. Antimicrob Agents Chemother (2004) 1.34
Direct detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis in auramine-rhodamine-positive sputum specimens by real-time PCR. J Clin Microbiol (2004) 1.32
Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis isolates in Spain and their rapid detection by PCR-enzyme-linked immunosorbent assay. J Clin Microbiol (2001) 1.27
Rapid detection of rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis isolates in shanghai by using the amplification refractory mutation system. J Clin Microbiol (2003) 1.11
Rapid diagnosis of extensively drug-resistant tuberculosis by use of a reverse line blot hybridization assay. J Clin Microbiol (2011) 1.10
Multi-probe real-time PCR identification of common Mycobacterium species in blood culture broth. J Mol Diagn (2008) 1.10
Genetic diversity, determined on the basis of katG463 and gyrA95 polymorphisms, Spoligotyping, and IS6110 typing, of Mycobacterium tuberculosis complex isolates from Italy. J Clin Microbiol (2005) 1.09
Simultaneous identification of Mycobacterium genus and Mycobacterium tuberculosis complex in clinical samples by 5'-exonuclease fluorogenic PCR. J Clin Microbiol (2002) 1.08
Rapid determination of rifampin resistance in clinical isolates of Mycobacterium tuberculosis by real-time PCR. J Clin Microbiol (2005) 1.06
Wolbachia pipientis growth kinetics and susceptibilities to 13 antibiotics determined by immunofluorescence staining and real-time PCR. Antimicrob Agents Chemother (2003) 1.01
Molecular testing for antibiotic resistance in Helicobacter pylori. Gut (2002) 0.92
Real-Time PCR: Revolutionizing Detection and Expression Analysis of Genes. Curr Genomics (2007) 0.84
Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria. Clin Microbiol Rev (2016) 0.84
Peptide nucleic acid-mediated competitive PCR clamping for detection of rifampin-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother (2004) 0.83
Visual detection of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis strains by use of an asymmetrically split peroxidase DNAzyme. J Clin Microbiol (2012) 0.83
Fast test for assessing the susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by real-time PCR. Mem Inst Oswaldo Cruz (2012) 0.81
Mycobacterium-inducible Nramp in striped bass (Morone saxatilis). Infect Immun (2004) 0.77
Genotyping Parkinson disease-associated mitochondrial polymorphisms. Clin Med Res (2004) 0.76
Identification of potential inhibitor targeting enoyl-acyl carrier protein reductase (InhA) in Mycobacterium tuberculosis: a computational approach. 3 Biotech (2013) 0.75
Detection of rpoB mutations in Mycobacterium tuberculosis with LightCycler technology. J Clin Microbiol (2002) 0.75
Rapid Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using Real-Time PCR. Jundishapur J Microbiol (2016) 0.75
Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques (1991) 21.69
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet (1993) 16.75
Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci U S A (1997) 15.25
The emergence of drug-resistant tuberculosis in New York City. N Engl J Med (1993) 12.71
The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature (1992) 11.99
inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science (1994) 11.22
Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet (1994) 9.20
Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol (1994) 6.91
Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol (1997) 5.09
Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch Pathol Lab Med (1995) 4.10
Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. Science (1998) 3.81
Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother (2000) 3.56
ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex. Mol Microbiol (1996) 2.48
Reliability of nucleic acid amplification for detection of Mycobacterium tuberculosis: an international collaborative quality control study among 30 laboratories. J Clin Microbiol (1996) 2.44
Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother (1997) 2.35
Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-strand conformation polymorphism and dideoxy fingerprinting. J Clin Microbiol (1995) 2.26
Biochemical and genetic data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis. J Infect Dis (1996) 2.13
Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. Clin Infect Dis (1997) 1.76
Use of real-time PCR and fluorimetry to detect lamivudine resistance-associated mutations in hepatitis B virus. Antimicrob Agents Chemother (1999) 1.41
Identification of pathogenic Leptospira genospecies by continuous monitoring of fluorogenic hybridization probes during rapid-cycle PCR. J Clin Microbiol (1997) 1.35
Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, Spain. Tuber Lung Dis (1999) 1.25
Molecular epidemiology of Mycobacterium tuberculosis strains isolated during a 3-year period (1993 to 1995) in Seville, Spain. J Clin Microbiol (1997) 1.02
Evaluation of Mycobacteria Growth Indicator Tube (m{spgit}) for drug susceptibility testing of Mycobacterium tuberculosis isolates from clinical specimens. Clin Microbiol Infect (1999) 0.93
An improved method for rapid screening of DNA mutations by nonradioactive single-strand conformation polymorphism procedure. Biotechniques (1993) 0.90
Activities of new quinoline derivatives against genital pathogens. Antimicrob Agents Chemother (1985) 2.51
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria. Antimicrob Agents Chemother (1980) 2.47
Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin. Circulation (1997) 2.17
Congenital and acquired thrombotic risk factors in women using oral contraceptives: clinical aspects. Clin Appl Thromb Hemost (2000) 1.99
Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J Clin Microbiol (2005) 1.60
Low level of circulating activated protein C is a risk factor for venous thromboembolism. Thromb Haemost (2001) 1.54
Modified test for activated protein C resistance. Lancet (1994) 1.53
Nosocomial transmission of tuberculosis infection in pediatrics wards. Pediatr Infect Dis J (1995) 1.52
Mortality and hospital stay related to coagulase-negative Staphylococci bacteremia in non-critical patients. J Infect (2012) 1.46
Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: studies in serum and plasma samples. J Urol (1998) 1.46
Cefoxitin sodium activity against anaerobes: effect of the inoculum size, pH variation and different culture media. J Antimicrob Chemother (1978) 1.32
Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville, Spain. Int J Tuberc Lung Dis (2002) 1.31
Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J (2007) 1.28
Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, Spain. Tuber Lung Dis (1999) 1.25
Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea. Sex Transm Dis (1986) 1.21
PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects. Br J Haematol (2000) 1.10
Late perforation of superior vena cava and effusion caused by central venous catheter. Anaesth Intensive Care (1981) 1.08
Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest (1991) 1.08
[Latex allergy in anesthesiology]. Rev Esp Anestesiol Reanim (1995) 1.07
Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood (1991) 1.05
Molecular epidemiology of Mycobacterium tuberculosis strains isolated during a 3-year period (1993 to 1995) in Seville, Spain. J Clin Microbiol (1997) 1.02
Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins. J Clin Invest (1993) 1.01
Determination of plasma malondialdehyde-like material and its clinical application in stroke patients. J Clin Pathol (1980) 1.01
DNA hybridization assay using ATTOPHOS, a fluorescent substrate for alkaline phosphatase. Biotechniques (1992) 0.99
Evaluation of a DNA probe of plasmid origin for the detection of Neisseria gonorrhoeae in cultures and clinical specimens. Mol Cell Probes (1991) 0.99
Diagnostic value of SCC, CEA and CYFRA 21.1 in lung cancer: a Bayesian analysis. Eur Respir J (1997) 0.99
Monitoring sedation in critically ill patients: bispectral index, Ramsay and observer scales. Eur J Anaesthesiol (2006) 0.97
Induction of anaesthesia with etomidate: haemodynamic study of 36 patients. Br J Anaesth (1980) 0.95
Characterization of Candida parapsilosis complex isolates. Clin Microbiol Infect (2011) 0.94
Serum malondialdehyde-like material (MDA-LM) in acute myocardial infarction. J Clin Pathol (1983) 0.94
Value of serological diagnosis in congenital syphilis. Report of nine cases. Br J Vener Dis (1980) 0.94
Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood (1994) 0.94
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa. J Antimicrob Chemother (1980) 0.92
Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia. Thromb Haemost (1998) 0.91
Detection of salmonellas by DNA hybridization with a fluorescent alkaline phosphatase substrate. J Appl Bacteriol (1992) 0.91
Fluorescent detection-polymerase chain reaction (FD-PCR) assay on microwell plates as a screening test for salmonellas in foods. J Appl Bacteriol (1993) 0.90
Comparative in-vitro activity of sparfloxacin against genital pathogens. J Antimicrob Chemother (1996) 0.90
Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis. Hum Reprod (2003) 0.90
Nosocomial outbreak of Pseudomonas aeruginosa endophthalmitis. Infect Control Hosp Epidemiol (2006) 0.89
Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia. Blood (1989) 0.89
Spontaneous cervical epidural hematoma associated with oral anticoagulant therapy. Clin Appl Thromb Hemost (2001) 0.88
Intracardiac thrombosis in a case of Behcet's disease associated with the prothrombin 20210G-A mutation. Haematologica (2000) 0.88
Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatment. Thromb Haemost (1990) 0.88
Plasma PAI-1 levels in obese children--effect of weight loss and influence of PAI-1 promoter 4G/5G genotype. Thromb Haemost (2001) 0.87
Modified sequential multiplex PCR for determining capsular serotypes of invasive pneumococci recovered from Seville. Clin Microbiol Infect (2010) 0.87
Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease. Thromb Haemost (1999) 0.87
Dysfunctional plasminogen in full-term newborn. Pediatr Res (1980) 0.86
Comparative activity of imipenem (N-formimidoyl thienamycin) on enterococci and its interactions with aminoglycosides. J Antimicrob Chemother (1984) 0.86
Homozygous form of the Pelger-Huët leukocyte anomaly in man. Acta Haematol (1981) 0.86
Heterogeneity of human prekallikrein deficiency (Fletcher trait): evidence that five of 18 cases are positive for cross-reacting material. N Engl J Med (1981) 0.86
Accidental diagnosis and resuscitation in a case of cardiac tamponade caused by central transvenous catheter. Crit Care Med (1981) 0.84
Comparison between plasmids of Salmonella and other enterobacteria isolated from the same patients. Ann Microbiol (Paris) (1982) 0.84
Warm ischemic time tolerance after ventilated non-heart-beating lung donation in piglets. Eur J Cardiothorac Surg (1998) 0.84
Prevalence of low HDL cholesterol, and relationship between serum HDL and cardiovascular disease in elderly Spanish population: the PREV-ICTUS study. Int J Clin Pract (2009) 0.84
Severe inherited "homozygous" protein C deficiency in a newborn infant. Thromb Haemost (1984) 0.84
Diagnostic value of cytokeratin fragment 19 (CYFRA 21-1) in bronchoalveolar lavage fluid in lung cancer. Respir Med (1998) 0.83
Circulating activated protein C is reduced in young survivors of myocardial infarction and inversely correlates with the severity of coronary lesions. J Thromb Haemost (2006) 0.83
Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic disease. Am J Pathol (1996) 0.83
Decreased expression of PAI-2 mRNA and protein in pregnancies complicated with intrauterine fetal growth retardation. Thromb Haemost (1996) 0.83
Hereditary homozygous heparin cofactor II deficiency and the risk of developing venous thrombosis. Thromb Haemost (1999) 0.83
Fibrinolytic activity and protein C in preeclampsia. Thromb Haemost (1986) 0.83
mRNA analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative RT-PCR assay. Hum Reprod (2004) 0.82
Inherited fibrinolytic disorder due to an enhanced plasminogen activator level. Thromb Haemost (1984) 0.82
Distribution of lesions in red and fallow deer naturally infected with Mycobacterium bovis. J Comp Pathol (2009) 0.82
Plasminogen activator inhibitors type 1 and type 2 and plasminogen activators in amniotic fluid during pregnancy. Thromb Haemost (1990) 0.82
Participation of tyrosine phosphorylation in cytoskeletal reorganization, alpha(IIb)beta(3) integrin receptor activation, and aspirin-insensitive mechanisms of thrombin-stimulated human platelets. Circulation (2000) 0.82
Role of red blood cells in the early stages of platelet activation by collagen. Thromb Haemost (1986) 0.82
Early platelet-collagen interactions in whole blood and their modifications by aspirin and dipyridamole evaluated by a new method (BASIC wave). Thromb Haemost (1985) 0.82
Global study of viral diarrhea in hospitalized children in Spain: results of structural surveillance of viral gastroenteritis net work (VIGESS-net) 2006-2008. J Clin Virol (2011) 0.81
Evaluation of plasminogen activators and plasminogen activator inhibitors in plasma and amniotic fluid in pregnancies complicated with intrauterine fetal growth retardation. Gynecol Obstet Invest (1994) 0.81
Letter: Thromboembolic accidents in patients with congenital deficiency of factor XII. Thromb Diath Haemorrh (1974) 0.81
[Changes in total and differential leukocyte counts during heart surgery with extracorporeal circulation]. Rev Esp Anestesiol Reanim (1991) 0.81
Iatrogenic myocardial dysfunction after formalization of the heart. Cardiovasc Dis (1981) 0.81
Evaluation of a fluorescent DNA hybridization assay for the detection of Neisseria gonorrhoeae. Eur J Clin Microbiol Infect Dis (1992) 0.81
Changes in molecular forms of prostate-specific antigen during treatment with finasteride. BJU Int (2002) 0.80
Platelet fatty acids in acute mycoadial infarction. Thromb Res (1979) 0.80
Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia. Am J Obstet Gynecol (1991) 0.80
Letter: Fibrinolytic activity in the endometrial adenocarcinoma. Thromb Diath Haemorrh (1975) 0.80
Evaluation of an automated method for the quantification of von Willebrand factor antigen. Its application in the study of vascular dysfunction. Haematologica (2001) 0.80
Alterations in erythrocyte aggregability in diabetics: the influence of plasmatic fibrinogen and phospholipids of the red blood cell membrane. Clin Hemorheol Microcirc (1998) 0.80
Reduced fibrinolytic activity in coronary heart disease in basal conditions and after exercise. Thromb Res (1985) 0.80
Identification of high molecular weight derivatives of plasmic digests of cross-linked human fibrin. Thromb Haemost (1978) 0.80
Adjusting positive end-expiratory pressure and tidal volume in acute respiratory distress syndrome according to the pressure-volume curve. Acta Anaesthesiol Scand (2003) 0.79
Red blood cell aggregation and primary hyperlipoproteinemia. Thromb Res (1993) 0.79
Effect of a modified fibrate (Biniwas Retard) on hemorheological alterations in hyperlipemic patients. Clin Hemorheol Microcirc (1999) 0.79
Sexually transmitted diseases in homosexual males in Seville, Spain. Genitourin Med (1991) 0.79
Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels. Thromb Haemost (1996) 0.79
Abruptio placentae and disseminated intravascular coagulation. Acta Obstet Gynecol Scand (1985) 0.79
Unstimulated and thrombin-stimulated platelets binding to immobilized fibrinogen and fibrin on polystyrene supports. Haemostasis (1995) 0.79
Acenocoumarol and 6-mercaptopurine: an important drug interaction. Haematologica (1999) 0.79
Effect of smoking on plasma and platelet fatty acid composition in middle-aged men. Atherosclerosis (1984) 0.79
Anaerobic bacteria in men with urethritis. J Eur Acad Dermatol Venereol (1998) 0.79
The determination of MDA as a simple technique for the control of the therapy with aspirin. Thromb Res (1979) 0.79